Related Experiment Videos

[Intravascular papillary endothelial hyperplasia: multiple lesions appearing in the course of treatment with

C Durieu1, P Bayle-Lebey, A Gadroy

  • 1Service de Dermatologie, Vénéréologie et Allergologie, CHU Purpan, place du Docteur Baylac, 31059 Toulouse.

Abstract

Insights

Multiple vascular lesions, a rare condition known as intravascular papillary endothelial hyperplasia, appeared on a patient's hands after beta-interferon treatment for multiple sclerosis. This case highlights a potential side effect of this therapy.

Area of Science:

  • Vascular pathology
  • Dermatology
  • Neurology

Background:

  • Intravascular papillary endothelial hyperplasia (IPEH) is a rare, benign vascular proliferation.
  • Multiple sclerosis (MS) is a chronic neurological disease often treated with immunomodulatory therapies.

Observation:

  • A 50-year-old male presented with multiple vascular nodules on his hands.
  • The patient had undergone 3 months of beta-interferon injections for multiple sclerosis.
  • Histopathological examination revealed characteristic features of IPEH.

Findings:

  • Histology confirmed IPEH, showing papillary endothelial proliferation within a dilated vessel lumen, accompanied by thrombosis.
  • The case is notable for the multiplicity and rarity of IPEH lesions in this context.
  • Differential diagnosis includes hemangiosarcoma, emphasizing the need for histological confirmation.

Implications:

  • This case suggests a potential association between beta-interferon therapy and the development of cutaneous vascular lesions like IPEH.
  • Further research into the pathogenesis of interferon-induced vascular lesions is warranted.
  • Understanding this association is crucial for managing patients with multiple sclerosis undergoing interferon treatment.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...